ModelEdge

PharmaCyte Biotech Inc.
PMCB
Filing Type8-K
Filing Date5/22/2024
Updated5/23/24, 2:40 PM

Filing

8-K
Earnings Release

Exhibits

8-KMaterial Contracts, Completing Asset Acquisition or Sale, Other Events
EX-10.1SECURITIES PURCHASE AGREEMENT, DATED MAY 20, BY AND AMONG PHARMACYTE BIOTECH, INC. AND MYMD PHARMACEUTICALS, INC.
EX-10.2FORM OF CERTIFICATE OF DESIGNATIONS OF SERIES G CONVERTIBLE PREFERRED STOCK OF MYMD PHARMACEUTICALS, INC.
EX-10.3FORM OF LONG-TERM WARRANT OF MYMD PHARMACEUTICALS, INC.
EX-10.4FORM OF SHORT-TERM WARRANT OF MYMD PHARMACEUTICALS, INC.
EX-10.5REGISTRATION RIGHTS AGREEMENT, DATED MAY 20, BY AND AMONG PHARMACYTE BIOTECH, INC. AND MYMD PHARMACEUTICALS, INC.
EX-99.1Material Contracts, Completing Asset Acquisition or Sale, Other Events
GRAPHICGraphic